ARCHIVES

FTC Report Disagrees With Key Provision Of Biologics Bill Backed By Companies

This article is from The Cancer Letter archive.

Vol. 35 No. 23 | June 12, 2009

Download PDF Visit The Full Archive

Related Articles

Amgen Pays $24.9 Million To Settle Kickback Charges

April 19, 2013

Dose Adjustments Of Other Drugs Questioned; Underdosing Or Overdosing?

October 15, 2010

NCI Seeks Applications For Small Business Research Awards

February 28, 1997

CCOPs, Research Base Awards Are Listed

November 19, 1993

Interview With Departing NCI Director; Advice To His Successor.

July 9, 2010

Coordination, Funding Lacking In National Cancer Program: Report

October 7, 1994